Which companies had cetuximab in development?

Which companies were developing cetuximab?

Cetuximab was developed by ImClone Systems and its partner company Bristol-Myers Squibb (BMS). Early development is commonly attributed to ImClone, with later clinical and commercialization efforts involving BMS. [1][2]

Who commercialized cetuximab and when?

After development work by ImClone, the drug was commercialized under the brand Erbitux. The commercialization rights and market presence were tied to Bristol-Myers Squibb’s role as partner for later-stage development and distribution. [1][2]

Were any other companies involved besides ImClone/BMS?

Public, widely cited development history for cetuximab centers on the ImClone–BMS collaboration. Other firms are more commonly seen later as developers of competing antibodies, biosimilars, or next-generation EGFR therapies rather than as original cetuximab developers. [1][2]

Sources

1
2